Form 4: Cryoport Executive Mark Sawicki Sells Shares to Cover Tax Obligations
SEC Form 4
Cryoport's Chief Scientific Officer, Mark Sawicki, sold 1,367 shares of common stock on March 25, 2024, to cover tax obligations related to vesting restricted stock rights.
Summary
- On March 25, 2024, Mark W Sawicki, Chief Scientific Officer of Cryoport, Inc. (CYRX), sold 1,367 shares of common stock.
- The sale was executed at a price of $17.5423 per share.
- The transaction was conducted to cover tax obligations arising from the vesting of restricted stock rights.
- Following the transaction, Sawicki directly owns 77,444 shares of Cryoport, Inc.
Sentiment
Score: 5
Explanation: The document describes a routine transaction (sale of shares to cover taxes). It doesn't indicate positive or negative sentiment.
Industry Context
This is a routine transaction related to executive compensation and tax obligations. It is common for executives to sell shares to cover taxes when restricted stock vests.
Stakeholder Impact
- The sale of shares by an executive could have a minor impact on shareholders, but is unlikely to be significant given the relatively small number of shares involved.
Key Dates
| Date | Description |
|---|---|
| 03/25/2024 | Date of transaction: Mark Sawicki sold shares of Cryoport common stock. |
| 03/26/2024 | Date of signature on the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.